Zephyrnet Logo

Tag: OTC

Juno-WuXi AppTec JV JW Therapeutics nabs $100M for cell therapy push

Back in 2016, Juno Therapeutics (now owned by Celgene, now owned by Bristol Myers) and WuXi AppTec joined forces to create a new...

Sanofi teams up with China biotech Alphamab for breast cancer R&D

French Big Pharma Sanofi, looking to bolster its cancer R&D, has penned a new pact with Alphamab Oncology that focuses on HER2-positive breast...

Novo helps lead Checkmate Pharmaceuticals’ $85M raise for single asset bet

Next-gen cancer biotech Checkmate Pharmaceuticals has grabbed a healthy series C round toward work on its all-or-nothing immuno-oncology hopeful. The biotech, which is...

Six Purdue innovators advance their technologies through Trask funding

WEST LAFAYETTE, Ind. – Six Purdue University researchers have received a total of $212,845 from the Trask Innovation Fund to help their labs...

SFC Concludes Consultation on OTC Derivatives Licensing Regime

The Securities and Futures Commission (SFC) of Hong Kong announced this week that it has concluded its consultation on the regulatory scope...

Blueberries Medical Corp Commences Sales of its Proprietary Cultivars

TORONTO – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis...

What You Need to Know About CNY Swaps

CNY Swaps are the 9th most traded interest rate swap at CCPs. The market is quite standardised, with 90% of volumes in just three...

Pfizer’s JAK abrocitinib comes through in teen eczema test

Hoping to carve out a niche in a tough market full of competitors, Pfizer has posted yet more positive data in atopic dermatitis....

AbbVie to pay Genmab $750M upfront to form bispecific R&D pact

AbbVie is set to pay Genmab $750 million upfront for a stake in a pipeline of anti-cancer bispecifics led by epcoritamab. The deal,...

Decoding COVID-19’s Achilles’ heel to inspire new treatments

As the highly infectious novel coronavirus continues to spread, scientists are looking for new ways to kill the virus. While Gilead Sciences’ repurposed...

Lilly pens antisense neuro pact with Evox Therapeutics

Eli Lilly is pretty busy with a series of partners working at breakneck speed on its antibody hopefuls for COVID-19, but that hasn’t...

Tradesmarter Relaunches as B2B Solution with Fixed Monthly Pricing

Tradesmarter, a white label trading solution, announced this Wednesday that it has relaunched its website, as well as changed its fee structure,...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?